An interventional study of Sleepiz One+ and Polysomnography in Sleep Apnea, sponsored by Sleepiz AG. Completed at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-01-25.
Sponsored by Sleepiz AG · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 37 studies in Sleep Apnea Syndromes with a site in Switzerland — 7 open to participants now, 9 under way, none of them phase 3. Sleep Apnea Syndromes · Switzerland.
Among the 37 studies in Sleep Apnea Syndromes with a site in Switzerland, this one is the 12th largest by enrollment of the 27 interventional ones that give a count, is one of 3 that started in 2020, is one of 21 with no phase, and was the 25th registered.
1,085 studies on the registry are indexed under Sleep Apnea Syndromes; 172 are open to participants now.
Browse Sleep Apnea Syndromes studies →7 of the 37 studies in Sleep Apnea Syndromes with a site in Switzerland are open now. Recruiting first, the newest first:
Insel Gruppe AG, University Hospital Bern · Sites in Switzerland
Ages 18+
Inspire Medical Systems, Inc. · Sites in Switzerland, Austria, Belgium and 4 more countries
Ages 18+
Solelhac Geoffroy · Sites in Switzerland
Ages 18+
Sleepiz AG · Sites in Switzerland
Ages 18+ · Healthy volunteers
AGIR à Dom · Sites in Switzerland, Canada, France
Ages 18–80 · Healthy volunteers
A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →
Of the 119 Sleep Apnea Syndromes studies recruiting now, 58 (49%) set no upper age limit and 37 (31%) stop at 75 or younger; 25 take children under 18; 28 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
37 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 3 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 64 is close to the median of 60 across 674 interventional studies indexed under Sleep Apnea Syndromes.
Median enrollment 60 across the 27 interventional studies, 196 across the 10 observational. Of the 22 that completed or were terminated, 1 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 37 have an industry lead sponsor. The 10 most frequent:
Sleepiz AG is the lead sponsor of 5 studies on the registry; 1 is open to participants now.
Sleepiz AG has 5 studies filed under Sleep Apnea Syndromes — fewer than ten, so there is no comparison to draw.
2 of the studies in Sleep Apnea Syndromes with a site in Switzerland that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06397365Solelhac GeoffroyEffect of Hypnosis on Adherence to Continuous Positive Airway Pressure. | 2027-02 |
| NCT07555119Insel Gruppe AG, University Hospital BernNight-to-Night Variability of Novel Physiological Parameters in Home Sleep Apnea Testing | 2027-06-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 37 studies in Sleep Apnea Syndromes with a site in Switzerland, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The primary aim of this study is to validate the performance of Sleepiz One+ for the measurement of vital physiological parameters in adult population, against a laboratory-based polysomnography. Additionally, the investigators will evaluate Sleepiz One+ ability to identify patients with a high risk of suffering from a sleep-related breathing disorder based on apnea-hypopnea index estimation. Participants will undergo measurement with Sleepiz One+ and a polysomnography device while resting in bed for 20 min as well as during sleep for the duration of the following night.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Device: Sleepiz One+ · Device: Polysomnography
Simultaneous sleep study with polysomnography and Sleepiz One+
Simultaneous sleep study with polysomnography and Sleepiz One+
Respiration rate measurement accuracy agreement
Time frame: 60 seconds
Binary classification of sleep apnea severity based on the AHI > 15 of Sleepiz One+ compared to results of Domino software and data manually scored by sleep technician
Time frame: 1 Night
Instantaneous respiration rate agreement between Sleepiz One+ and nasal cannula
Time frame: 60 seconds
Average respiration rate agreement between Sleepiz One+ and thoracic respiratory effort belt
Time frame: 1 Night
Average respiration rate agreement between Sleepiz One+ and nasal cannula
Time frame: 1 Night
Sleep/wake classification agreement between Sleepiz One+ compared to polysomnography (PSG) data manually scored by sleep technician
Time frame: 60 seconds
Plan to share: No
No publications or documents are linked to this record.
Ran from Sep 2020 to primary completion in Feb 2021, 4 months.
Of 69 industry-sponsored interventional studies with no phase under Sleep Apnea Syndromes, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 18. This study's 4 months is below that.
Counting every sponsor, half of 271 studies reached it within 26 months; a quarter within 11 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sleepiz AG